Management of Digestive Haemorrhaging In CHRU of Brest During 2009 and 2014

Risk Factors for Further Bleeding in Patients Admitted to Intensive Care for Gastro Intestinal Bleeding

Status

Completed

Phases

Unknown

Study type

Observational

Source

ClinicalTrials.gov

Registry ID

NCT03379285

Acronym

HDréa

Enrollment

272

Registered

2017-12-20

Start date

2016-10-03

Completion date

2016-12-31

Last updated

2017-12-20

For informational purposes only — not medical advice. Sourced from public registries and may not reflect the latest updates. Terms

Conditions

Gastro Intestinal Bleeding

Keywords

Gastro Intestinal Bleeding;, Transfusion,, Outcomes

Brief summary

Gastro intestinal (GI) bleeding is relatively frequent and may lead to intensive care unit admission. Although a restrictive strategy for red blood cell transfusion is supported by a large randomized controlled trial literature, less is known about the impact of transfusion strategy of other blood components and administration of anti fibrinolytic on clinical outcomes. This study aims to identify parameters that may be associated with the risk of further bleeding in patients admitted to ICU for GI bleeding.

Interventions

None listed

Study design

Observational model

COHORT

Time perspective

RETROSPECTIVE

Eligibility

Sex/Gender

ALL

Age

18 Years to No maximum

Healthy volunteers

Inclusion criteria

* Patients with Gastro Intestinal Bleeding admitted to either medical or surgical intensive care unit

Exclusion criteria

* patients retrieved from another hospital * age \< 18 years consent withdrawal

Design outcomes

Primary

Measure	Time frame	Description
Bleeding	within a week	Bleeding persistance or recidive requiring an intervention or a scope

Secondary

Measure	Time frame	Description
mortality	during hospitalisation (28 days)	hospital mortality

Countries

France

Outcome results